Author:
Mendell Jeanne,Tachibana Masaya,Shi Minggao,Kunitada Satoshi
Subject
Pharmacology (medical),Pharmacology
Reference14 articles.
1. DU-176b a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles;Furugohri;J Thromb Haemost,2008
2. Clinical safety, tolerability, pharmacokinetics and pharmacodynamics of the novel factor Xa inhibitor edoxaban in healthy volunteers;Ogata;J Clin Pharmacol,2010 Jan 15
3. Randomized, parallel group, multicenter, multinational study evaluating safety of DU-176b compared with warfarin in subjects with non-valvular atrial fibrillation;Weitz;Blood,2008
4. Randomized, double-blind, multi-dose efficacy, safety and biomarker study of the oral factor Xa inhibitor DU-176b compared with placebo for prevention of venous thromboembolism in patients after total knee arthroplasty [abstract];Fuji;Blood,2008
5. Randomized double-blind, multi-dose trial of the oral factor Xa inhibitor DU-176b versus LMWH heparin (dalteparin) for prevention of venous thromboembolism after total hip replacement;Raskob;Eur Heart J,2008
Cited by
106 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献